This Slide: #31 of 100 |
Slide #31. Globus Medical — Excelsius Surgical
Acquirer:
Globus Medical (NYSE:GMED)
Acquiree:
Excelsius Surgical
Details:
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical. Excelsius Surgical is developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets. The Excelsius Surgical system is a robotic surgical aid for navigating and facilitating surgical access, implant sizing, positioning and placement, and is designed to enable surgeons to perform procedures more quickly and with greater accuracy, safety and reproducibility than is currently available in the marketplace today.
Globus Medical is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. Co. focuses on medical device development and delivering service to hospitals, ambulatory surgery centers and physicians. Co.'s product categories are: Musculoskeletal Solutions, which include implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures; and Enabling Technologies, which include imaging, navigation and robotics solutions for assisted surgery which are computer-assisted intelligent systems designed to improve a surgeon's capabilities and improve patient care.
GMED SEC Filing Email Alerts Service
Open the GMED Page at The Online Investor »
|
Open the GMED Page at The Online Investor (in a new window) »
Free GMED Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (2.80 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Analysts' Target Price: GMED Stock Forecast Based on Zacks ABR data; powered by Xignite |